PropertyValue
?:abstract
  • The Centers for Medicare & Medicaid Services (CMS) and other federal agencies are busy churning out regulations and guidance documents in response to the COVID-19 crisis. CMS now requires plans to waive cost sharing for COVID-19-related immunizations, testing, and treatment and suspend utilization review requirements related to drug-supply limits unless these limits are related to patient safety.
?:creator
?:doi
  • 10.4140/tcp.n.2020.331.
?:doi
?:journal
  • The_Senior_care_pharmacist
?:license
  • unk
?:pmid
?:pmid
  • 32600512.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • CMS Responds to COVID-19 Crisis by Revising Regulations.
?:type
?:year
  • 2020-07-01

Metadata

Anon_0  
expand all